182 related articles for article (PubMed ID: 35733230)
1. Active surveillance of carbapenem-resistant gram-negative bacteria to guide antibiotic therapy: a single-center prospective observational study.
Liang Q; Chen J; Xu Y; Chen Y; Huang M
Antimicrob Resist Infect Control; 2022 Jun; 11(1):89. PubMed ID: 35733230
[TBL] [Abstract][Full Text] [Related]
2. A Longitudinal Study of Spontaneous Gut Decolonization of Carbapenem-resistant Gram-negative Bacteria in Neonatal and Pediatric Patients.
Darda VM; Iosifidis E; Antachopoulos C; Kirvasilis F; Zarras C; Simitsopoulou M; Papakonstantinou E; Agakidou E; Sdougka M; Roilides E
Pediatr Infect Dis J; 2022 Aug; 41(8):648-653. PubMed ID: 35446811
[TBL] [Abstract][Full Text] [Related]
3. Effects of an Active Surveillance Program and Enhanced Infection Control Measures on Carbapenem-Resistant Gram-Negative Bacterial Carriage and Infections in Pediatric Intensive Care.
Karampatakis T; Tsergouli K; Iosifidis E; Antachopoulos C; Volakli E; Karyoti A; Sdougka M; Tsakris A; Roilides E
Microb Drug Resist; 2019 Nov; 25(9):1347-1356. PubMed ID: 31364923
[TBL] [Abstract][Full Text] [Related]
4. Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care.
Karampatakis T; Tsergouli K; Iosifidis E; Antachopoulos C; Karapanagiotou A; Karyoti A; Gritsi-Gerogianni N; Tsakris A; Roilides E
J Hosp Infect; 2018 Aug; 99(4):396-404. PubMed ID: 29792971
[TBL] [Abstract][Full Text] [Related]
5. A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria.
Ferrer R; Soriano A; Cantón R; Del Pozo JL; García-Vidal C; Garnacho-Montero J; Larrosa N; Rascado P; Salavert M; Pintado V; Giró-Perafita N; Badia X
Rev Esp Quimioter; 2022 Oct; 35(5):455-467. PubMed ID: 35859521
[TBL] [Abstract][Full Text] [Related]
6. Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.
Andria N; Henig O; Kotler O; Domchenko A; Oren I; Zuckerman T; Ofran Y; Fraser D; Paul M
J Antimicrob Chemother; 2015 Nov; 70(11):3146-53. PubMed ID: 26209312
[TBL] [Abstract][Full Text] [Related]
7. Is surveillance for colonization of carbapenem-resistant gram-negative bacteria important in adult bone marrow transplantation units?
Demiraslan H; Cevahir F; Berk E; Metan G; Cetin M; Alp E
Am J Infect Control; 2017 Jul; 45(7):735-739. PubMed ID: 28214159
[TBL] [Abstract][Full Text] [Related]
8. Effect on 30-day mortality and duration of hospitalization of empirical antibiotic therapy in CRGNB-infected pneumonia.
Li R; Tang H; Xu H; Cui K; Li S; Shen J
Ann Clin Microbiol Antimicrob; 2021 Mar; 20(1):15. PubMed ID: 33678191
[TBL] [Abstract][Full Text] [Related]
9. Modifiable risk factors associated with later gut decolonization of carbapenem-resistant Gram-negative bacteria in children: a prospective cohort study.
Darda VM; Iosifidis E; Antachopoulos C; Kirvasilis F; Zarras C; Haidich AB; Papakonstantinou E; Kontou A; Sdougka M; Roilides E
J Hosp Infect; 2023 Jun; 136():75-84. PubMed ID: 37075817
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, antimicrobial resistance, and mortality risk factors of carbapenem resistant gram-negative bacteria in hematopoietic stem cell transplantation recipients.
Jia Y; Li Y; Liu Y; Yang Z; Chen X; Liu Y
Front Cell Infect Microbiol; 2022; 12():1098856. PubMed ID: 36710978
[TBL] [Abstract][Full Text] [Related]
11. Changing Epidemiology and Decreased Mortality Associated With Carbapenem-resistant Gram-negative Bacteria, 2000-2017.
Babiker A; Clarke LG; Saul M; Gealey JA; Clancy CJ; Nguyen MH; Shields RK
Clin Infect Dis; 2021 Dec; 73(11):e4521-e4530. PubMed ID: 32990319
[TBL] [Abstract][Full Text] [Related]
12. Prediction of carbapenem-resistant gram-negative bacterial bloodstream infection in intensive care unit based on machine learning.
Liang Q; Ding S; Chen J; Chen X; Xu Y; Xu Z; Huang M
BMC Med Inform Decis Mak; 2024 May; 24(1):123. PubMed ID: 38745177
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem-resistant Gram-negative bacteria: how to prioritize infection prevention and control interventions in resource-limited settings?
Apisarnthanarak A; Hsu LY; Khawcharoenporn T; Mundy LM
Expert Rev Anti Infect Ther; 2013 Feb; 11(2):147-57. PubMed ID: 23409821
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy.
Crusio R; Rao S; Changawala N; Paul V; Tiu C; van Ginkel J; Chapnick E; Kupfer Y
Scand J Infect Dis; 2014 Jan; 46(1):1-8. PubMed ID: 24206450
[TBL] [Abstract][Full Text] [Related]
15. Intraventricular or intrathecal polymyxin B for treatment of post-neurosurgical intracranial infection caused by carbapenem-resistant gram-negative bacteria: a 8-year retrospective study.
Hu Y; Li D; Zhang G; Dai Y; Chen M; Jiang H; Cui W
Eur J Clin Microbiol Infect Dis; 2024 May; 43(5):875-884. PubMed ID: 38443737
[TBL] [Abstract][Full Text] [Related]
16. Forecasting models of infections due to carbapenem-resistant Gram-negative bacteria in an intensive care unit in an endemic area.
Karampatakis T; Tsergouli K; Iosifidis E; Antachopoulos C; Mouloudi E; Karyoti A; Tsakris A; Roilides E
J Glob Antimicrob Resist; 2020 Mar; 20():214-218. PubMed ID: 31265930
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study.
Zak-Doron Y; Dishon Benattar Y; Pfeffer I; Daikos GL; Skiada A; Antoniadou A; Durante-Mangoni E; Andini R; Cavezza G; Leibovici L; Yahav D; Eliakim-Raz N; Carmeli Y; Nutman A; Paul M;
Clin Infect Dis; 2018 Nov; 67(12):1815-1823. PubMed ID: 29718143
[TBL] [Abstract][Full Text] [Related]
18. Impact of Preemptive Granulocyte Infusions During Febrile Neutropenia in Patients Colonized with Carbapenem-Resistant Gram-Negative Bacteria Undergoing Haploidentical Transplantation.
Jaiswal SR; Bhakuni P; Bhagwati G; Joy A; Chakrabarti A; Chakrabarti S
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1621-1628. PubMed ID: 31048086
[TBL] [Abstract][Full Text] [Related]
19. Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli.
Zeng M; Xia J; Zong Z; Shi Y; Ni Y; Hu F; Chen Y; Zhuo C; Hu B; Lv X; Li J; Liu Z; Zhang J; Yang W; Yang F; Yang Q; Zhou H; Li X; Wang J; Li Y; Ren J; Chen B; Chen D; Wu A; Guan X; Qu J; Wu D; Huang X; Qiu H; Xu Y; Yu Y; Wang M; ; ;
J Microbiol Immunol Infect; 2023 Aug; 56(4):653-671. PubMed ID: 36868960
[TBL] [Abstract][Full Text] [Related]
20. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.
Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J
Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137
[No Abstract] [Full Text] [Related]
[Next] [New Search]